Mirati Therapeutics, Inc.
MRTX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$161,904 | -$176,913 | -$184,586 | -$202,475 |
| Dep. & Amort. | $1,115 | $1,107 | $1,075 | $891 |
| Deferred Tax | -$122,228 | -$144,155 | $0 | $0 |
| Stock-Based Comp. | $44,553 | $39,399 | $46,961 | $61,607 |
| Change in WC | -$22,600 | $11,648 | -$48,576 | $16,887 |
| Other Non-Cash | $117,351 | $137,514 | -$5,056 | -$5,710 |
| Operating Cash Flow | -$143,713 | -$131,400 | -$190,182 | -$128,800 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$36 | -$722 | -$269 | -$810 |
| Net Acquisitions | $62,158 | -$16,254 | -$195,420 | -$60,107 |
| Inv. Purchases | -$341,662 | -$237,048 | -$126,708 | -$237,333 |
| Inv. Sales/Matur. | $279,504 | $253,302 | $322,128 | $297,440 |
| Other Inv. Act. | -$62,158 | $16,254 | $195,420 | $60,107 |
| Investing Cash Flow | -$62,194 | $15,532 | $195,151 | $59,297 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $329,187 | $3,328 | $1,727 | $155,011 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $334,700 | $3,843 | $1,727 | $5,920 |
| Financing Cash Flow | $334,700 | $3,843 | $1,727 | $5,920 |
| Forex Effect | $59 | -$34 | -$31 | $0 |
| Net Chg. in Cash | $128,852 | -$112,059 | $6,665 | -$63,583 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $130,486 | $242,545 | $235,880 | $299,463 |
| End Cash | $259,338 | $130,486 | $242,545 | $235,880 |
| Free Cash Flow | -$143,749 | -$132,122 | -$190,451 | -$129,610 |